Select Medical Holdings Corporation  

(Public, NYSE:SEM)   Watch this stock  
Find more results for SEM
13.38
-0.21 (-1.55%)
Apr 29 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 13.19 - 13.59
52 week 7.33 - 17.20
Open 13.53
Vol / Avg. 0.00/642,393.00
Mkt cap 1.73B
P/E 13.46
Div/yield 0.10/2.99
EPS 0.99
Shares 131.29M
Beta 1.41
Inst. own 84%
May 6, 2016
Q1 2016 Select Medical Holdings Corp Earnings Call - 9:00AM EDT - Add to calendar
May 5, 2016
Q1 2016 Select Medical Holdings Corp Earnings Release - 4:00PM EDT - Add to calendar
Apr 26, 2016
Select Medical Holdings Corp Annual Shareholders Meeting (Estimated)
Apr 25, 2016
Select Medical Holdings Corp Annual Shareholders Meeting
Feb 26, 2016
Q4 2015 Select Medical Holdings Corp Earnings Call
Feb 25, 2016
Q4 2015 Select Medical Holdings Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 2.49% 3.63%
Operating margin 5.99% 7.34%
EBITD margin - 10.15%
Return on average assets 2.37% 3.70%
Return on average equity 13.53% 15.88%
Employees 28,400 -
CDP Score - -

Address

4714 Gettysburg Rd
MECHANICSBURG, PA 17055-4325
United States - Map
+1-717-9721100 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Select Medical Holdings Corporation is an operator of both specialty hospitals and outpatient rehabilitation clinics in the United States based on number of facilities. The Company operates in two business segments: specialty hospital segment and outpatient rehabilitation segment. The Company specialty hospital segment consists of hospitals designed to serve the needs of long term stay acute care patients and hospitals designed to serve patients who require intensive inpatient medical rehabilitation care. The Company outpatient rehabilitation segment consists of clinics and contract therapy locations that provide physical, occupational and speech rehabilitation services. The Company also provides medical rehabilitation services on a contract basis at nursing homes, hospitals, assisted living and senior care centers, schools and worksites. As of December 31, 2014, the Company had operations in 41 states and the District of Columbia.

Officers and directors

Robert A. Ortenzio Executive Chairman of the Board, Co-Founder
Bio & Compensation  - Reuters
David S. Chernow President, Chief Executive Officer
Bio & Compensation  - Reuters
Rocco A. Ortenzio Vice Chairman of the Board, Co-Founder
Bio & Compensation  - Reuters
Martin F. Jackson Chief Financial Officer, Executive Vice President
Age: 52
Bio & Compensation  - Reuters
John A. Saich Executive Vice President, Chief Human Resources Officer
Bio & Compensation  - Reuters
Michael E. Tarvin Executive Vice President, General Counsel, Secretary
Bio & Compensation  - Reuters
Scott A. Romberger Senior Vice President, Chief Accounting Officer, Controller
Bio & Compensation  - Reuters
Robert G. Breighner Jr. Vice President - Compliance and Audit Services, Corporate Compliance Officer
Bio & Compensation  - Reuters
Russell L. Carson Director
Bio & Compensation  - Reuters
Thomas A. Scully Director
Bio & Compensation  - Reuters